Aspen Aerogels (NYSE:ASPN) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Aspen Aerogels (NYSE:ASPN) from a sell rating to a hold rating in a research report report published on Saturday morning,Wall Street Zen reports.

A number of other equities research analysts also recently issued reports on ASPN. Barclays boosted their target price on shares of Aspen Aerogels from $4.00 to $5.00 and gave the company an “underweight” rating in a report on Tuesday, August 11th. B. Riley Financial reaffirmed a “buy” rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Roth Capital reiterated a “buy” rating and set a $7.75 price objective on shares of Aspen Aerogels in a research note on Friday, August 7th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, September 21st. Four research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Aspen Aerogels presently has a consensus rating of “Hold” and an average target price of $5.94.

Aspen Aerogels Trading Down 4.3%

Shares of NYSE:ASPN opened at $4.83 on Friday. Aspen Aerogels has a 12 month low of $2.30 and a 12 month high of $8.23. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.52 and a quick ratio of 2.24. The business’s 50 day simple moving average is $5.24 and its 200-day simple moving average is $4.67.

Aspen Aerogels (NYSE:ASPN) last posted its earnings results on Thursday, August 6th. The construction company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. The firm had revenue of $49.85 million during the quarter, compared to the consensus estimate of $42.42 million. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. Equities analysts anticipate that Aspen Aerogels will post -0.69 EPS for the current year.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, major shareholder Wood River Capital, Llc sold 12,280,426 shares of Aspen Aerogels stock in a transaction on Wednesday, September 23rd. The shares were sold at an average price of $4.73, for a total value of $58,086,414.98. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.96% of the stock is owned by company insiders.

Institutional Trading of Aspen Aerogels

Several hedge funds have recently made changes to their positions in the stock. BlackRock Inc. bought a new position in shares of Aspen Aerogels during the second quarter worth about $33,457,000. Palogic Value Management L.P. bought a new position in shares of Aspen Aerogels in the second quarter valued at $1,177,000. Deutsche Bank AG purchased a new stake in shares of Aspen Aerogels during the second quarter valued at $2,359,000. Baird Financial Group Inc. acquired a new stake in Aspen Aerogels during the 2nd quarter worth about $2,189,000. Finally, George Kaiser Family Foundation acquired a new position in shares of Aspen Aerogels in the second quarter worth about $20,081,000. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc is an advanced materials company that develops, manufactures and sells aerogel-based products. Aerogels are highly porous materials used for thermal management, insulation and protection. The company serves customers in the energy, industrial, transportation and building materials markets.

Its product portfolio includes thermal barriers designed to help protect electric vehicle batteries from thermal runaway, as well as insulation products for industrial, energy infrastructure and building applications.